SSII

Over the past six months, SS Innovations International, Inc. completed a private placement on March 6, 2026, raising approximately $18.6 million. Regulatory approvals for its SSi Mantra system were announced in Colombia, Oman, Sri Lanka, and Kenya in March 2026, and it was approved for telesurgeries in Indonesia and the Philippines. In April 2026, the company unveiled cutting-edge surgical robotic technologies at the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) in New Delhi, India. In May 2026, the company announced that over 10,500 cumulative surgeries had been successfully performed with the SSi Mantra surgical robotic system as of April 30, 2026. Long-distance telesurgery capabilities were demonstrated at the Royal Australian College of Surgeons Annual Scientific Congress in May 2026, and the company announced the completion of robotic telesurgery for weight loss and a 4,500-mile cross-border telesurgery. In May 2026, SS Innovations filed an S-3 for a $150M shelf offering and 5.02M shares registered for resale. SSII's stock decreased by 31.9% from the beginning of 2026 to May 9, 2026, with a weekly volatility of 15%.